Quick Answer
Vanda Pharmaceuticals Inc. reported Shares Outstanding of 59.10 million shares for fiscal year 2025.
Vanda Pharmaceuticals Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 59.10M | +1.4% |
| 2024 | 58.31M | +1.3% |
| 2023 | 57.53M | +1.3% |
| 2022 | 56.78M | +1.6% |
| 2021 | 55.90M | +1.9% |
| 2020 | 54.87M | +2.5% |
| 2019 | 53.55M | +2.0% |
| 2018 | 52.48M | +16.8% |
| 2017 | 44.94M | +2.1% |
| 2016 | 44.00M | +2.8% |
| 2015 | 42.82M | +3.2% |
| 2014 | 41.49M | +24.4% |
| 2013 | 33.34M | +18.0% |
| 2012 | 28.24M | +0.4% |
| 2011 | 28.12M | +0.3% |
| 2010 | 28.04M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 59.10M | +1.4% | +0.0% |
| June 30, 2025 | 59.08M | +1.4% | +0.2% |
| March 31, 2025 | 58.93M | +1.3% | +1.1% |
| December 31, 2024 | 58.31M | +1.3% | +0.0% |
| September 30, 2024 | 58.31M | +1.3% | +0.0% |
| June 30, 2024 | 58.29M | +1.4% | +0.2% |
| March 31, 2024 | 58.20M | +1.3% | +1.2% |
| December 31, 2023 | 57.53M | +1.3% | +0.0% |
- Vanda Pharmaceuticals Inc. showed an increase of +1.4% in Shares Outstanding compared to the prior fiscal year.
- Over the 2010–2025 period, Vanda Pharmaceuticals Inc.’s shares outstanding has grown by 110.8% (from 28.04 million shares to 59.10 million shares).
- The most recent figure is from Vanda Pharmaceuticals Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 12, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: